Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be used ...
A study, published this month in the journal JAMA Psychiatry, sought to determine whether “a single psychedelic dose of psilocybin with psychotherapy demonstrate[s] evidence for efficacy and/or safety ...
Depression and Bipolar Support Alliance (DBSA) Berkeley holds meetings every Wednesday at Immaculate Conception Church in Goose Creek from 7 to 8 p.m. for those struggling with depression and bipolar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results